SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is trending as investors debate its long-term potential as a reliable payment-focused digital asset versus its recent price underperformance compared to other crypto coins. The community is intensely focused on technical indicators, potential institutional interest, and the network's resilience as they watch for a breakout from current consolidation levels.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending following positive Phase 3 results for its hereditary angioedema therapy, despite facing volatility from a recent equity offering. While some investors are concerned about dilution, community sentiment remains heavily focused on the stock's significant short interest, with many anticipating a potential squeeze driven by the company's long-term commercialization prospects.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing increased engagement driven by a mix of broader crypto market momentum, technical breakout patterns, and persistent community speculation regarding its long-term potential in the data economy and AI-linked IoT sectors. While some investors remain highly optimistic about upcoming infrastructure and governance developments, others caution against volatility and remain skeptical, highlighting the ongoing divide between long-term proponents and those wary of past performance.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

Troll is gaining momentum as market participants increasingly highlight its status as an established meme with original IP rights and a growing community presence. Investors are actively drawing parallels to past major market cycles while debating its potential for future growth alongside other prominent meme-sector assets.

What makes MOG an absolute game-changer is our relentless dedication to memes and viral brilliance! We don't settle for mediocrity; we plunge into the realm of sheer awesomeness! Our community is a powerhouse of meme warriors, unleashing an unstoppable onslaught of viral memes that'll leave you in awe and stitches!  We're not here to play games; we're here to dominate! MOG is all about pushing the boundaries, smashing through barriers, and leaving our competitors eating our dust! Our passion for humor burns like an inferno, and we won't rest until the entire internet bows down to our meme supremacy!  And our community? It's a brotherhood, an unyielding powerhouse of support and camaraderie! When you're part of MOG, you're part of an unstoppable force, a family forged by the fire of meme revolution!  So, if you're ready to be part of the most intense, mind-bending memecoin movement ever conceived, then buckle up, strap in, and brace yourself! MOG is here to claim the throne, and we're taking no prisoners! Get ready to witness meme history in the making!

 MOG Coin

MOG Coin is trending amid high volatility as community members debate whether the asset represents a significant accumulation opportunity or a speculative pump-and-dump scheme. The discourse is fueled by broader market anticipation of crypto-friendly policy shifts, with participants actively weighing social sentiment and price action against warnings of potential downside.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF (SCHD) is trending as investors favor its defensive stability and dividend growth amidst broader market volatility, with community members actively discussing its role as a core portfolio anchor and comparing it to high-growth tech alternatives.

Analog Devices, Inc. is a semiconductor company, which engages in the combination of analog, digital, and software technologies into engineering solutions. Its products include analog and mixed signals, power management and reference, amplifiers radio frequency, and reference, sensors and actuators, and digital signal processing and system. The company was founded by Raymond P. Stata and Matthew Lorber in 1965 and is headquartered in Wilmington, MA.

Analog Devices Inc.

Analog Devices is trending as a key beneficiary of the AI infrastructure boom, with the community highlighting its essential role in power architecture and precision analog technology for high-efficiency data centers. Investors are closely monitoring the stock following strong quarterly performance and strategic moves to bolster its position in the rapidly expanding AI power and electrification market.

ProShares Trust II - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver (AGQ) is seeing intense volatility as investors debate the impact of geopolitical conflicts, potential peace deals, and ongoing concerns about silver supply shortages and COMEX inventory levels. Community discourse is highly polarized, with many traders focused on leveraging intraday fluctuations while debating whether the metal is being manipulated by major financial institutions.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending as investors debate whether the current price action signals a bottoming phase or a continuation of a multi-year downtrend. While some community members highlight upcoming network upgrades and long-term tokenization potential, the conversation is dominated by intense skepticism from traders who view it as a declining asset and are actively betting against its recovery.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Power and Energy, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Power and Energy segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925, and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillar is trending as institutional investors and the trading community scrutinize its transition into an 'AI infrastructure' play, bolstered by the massive demand for backup power in data centers. While some community members celebrate the stock's historic momentum and dividend increases, others remain skeptical, citing elevated valuations and warning of a potential correction as it continues to decouple from traditional industrial cycles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALT I had a lot of time to research yesterday and decided to learn a lot more about Durso and how his last transaction at Intercept went down and a massive peace and confidence came over me. I summarized my thoughts and shared them via email while flying home to a couple hundred of our ALT retail investors on here. I highly encourage all of you to also research the Intercept transaction and our retail shorts that might just be here for momentum.  
 
Jerry Durso initiated a competitive bid process for Intercept, (during a very non-advantageous time for Intercept based on FDA actions on their molecule) and was able to secure multiple bids after their bank solicited 19 interested parties. The bid winner also increased their final price by over $3 to $19 a share.  
 
This was a very short process as well.  
 
I doubt he will decide to make the process public (hopefully the rumors start coming out this weekend) but this process has most certainly already started for us. We have the goods now, we are not in a place of weakness and it is go time, end of Phase 2 for MASH and Obesity, Breakthrough Status granted and Phase 3 Trial Design with PathAI assisted biopsies as an Accelerated Approval endpoint.  
 
The calm and confidence I gained from learning about their auction process is understanding he will get a deal done, we all have fun debating lofty and realistic valuations but regardless, he is going to get one done and have multiple companies competing for Pemvi. I promise you the process has already started.  
 
Whether it is $2 billion or $5 billion is yet to be seen but either way, a transaction is coming and I hope they start signaling that big time publicly. It is also very strange right now we didn&#39;t post on social media our biggest catalyst ever and IR has gone completely dark on me and everyone else....Something is cooking. Get your hands on as many shares as you can, screw options.

The Machine

Keston Andrew

Wayside Sanford

paul roger

Maxim W

MJ Candlec

Ivan Larsson

Marv

Chris

Allen

Lynxtail

Blank Stocker

Jan Paul Beahm

Sett Mon Min

Greg

Paul Fisher

szrdz

VINCE_CARTER

CommonRyobiUser

Adam42

Scott Loftin

Littlebuylittle

Chardee MacDennis

Mary OReilly

Walter

Spoonie Spoon

Biotech And Real Estate

Roman Kudrin

$ALT I can&#39;t find anywhere (other than $ALT Pervi defensive posts) that $ALT will pursue Fibrosis Improvement as a trial endpoint in P3.  Furthermore, I haven&#39;t seen the scope of what $ALT ACTUALLY received Breakthrough Designation for.  I understand &quot;MASH&quot;, but is is solely MASH resolution or does it include other areas?   
 
I think for those Pervi&#39;s out there pumping $ALT, it would do you good to research what has actually happened and what hasn&#39;t.  And if your defense is that $ALT hasn&#39;t told you so you can&#39;t answer, then act on that...not pumping lies and misinformation.   
 
Can&#39;t wait to see this MASSIVE P3 trial design that&#39;s going to bleed money and bring $ALT shareholders further from profitability. 
 
Cheers!

StockTwits Web

The Legendary Mayor

$ALT I didn&#39;t get Britt&#39;s email, but I heard he confirmed $ALT is NOT pursuing Fibrosis in P3, only MASH and some NITs.   

Can anyone confirm this?

StockTwits For Android 

$ALT Where&#39;s the outrage on this board for this FUD and admitted LIE by @Diapers_Tequila?  @Wolly99 and @Designed2Gain, I expect , for your own integrity with the SEC (and to not add to the harrassment case against each of you for your threats and attacks against me), you will be reporting Britt for these fraudulent statements to the SEC.  Also, the 66 of you that hearted Britt&#39;s post are complicit in encouraging this fraudulent activity.  

Legal and Civil don&#39;t play favorites or emotions, they evaluate content.  That is where I am clear and win, and others stand to lose.  Social harrassment is not a victimless crime and increasingly frowned upon by regulatory agencies.

$ALT I keep seeing lazy FUDsters quoting Durso’s entire tenure at Intercept as the timeline it took him to get it sold.  That’s incorrect.  FDA rejected their MASH molecule Ocaliva in June 2023.  BO in September 2023.  
Facts matter. 🤓

StockTwits for iOS

Turribull

Altimmune Inc

 I had a lot of time to research yesterday and decided to learn a lot more about Durso and how his last transaction at Intercept went down and a massive peace and confidence came over me. I summarized my thoughts and shared them via email while flying home to a couple hundred of our ALT retail investors on here. I highly encourage all of you to also research the Intercept transaction and our retail shorts that might just be here for momentum.  
 
Jerry Durso initiated a competitive bid process for Intercept, (during a very non-advantageous time for Intercept based on FDA actions on their molecule) and was able to secure multiple bids after their bank solicited 19 interested parties. The bid winner also increased their final price by over $3 to $19 a share.  
 
This was a very short process as well.  
 
I doubt he will decide to make the process public (hopefully the rumors start coming out this weekend) but this process has most certainly already started for us. We have the goods now, we are not in a place of weakness and it is go time, end of Phase 2 for MASH and Obesity, Breakthrough Status granted and Phase 3 Trial Design with PathAI assisted biopsies as an Accelerated Approval endpoint.  
 
The calm and confidence I gained from learning about their auction process is understanding he will get a deal done, we all have fun debating lofty and realistic valuations but regardless, he is going to get one done and have multiple companies competing for Pemvi. I promise you the process has already started.  
 
Whether it is $2 billion or $5 billion is yet to be seen but either way, a transaction is coming and I hope they start signaling that big time publicly. It is also very strange right now we didn't post on social media our biggest catalyst ever and IR has gone completely dark on me and everyone else....Something is cooking. Get your hands on as many shares as you can, screw options.

Britt Peterson

Beer Good.

Corpkcots

@Diapers_Tequila you promise the process has already started? Wow thanks!! Do you have a timeframe whe it will be complete? I might go long then before the buyout

 you promise the process has already started? Wow thanks!! Do you have a timeframe whe it will be complete? I might go long then before the buyout

@Diapers_Tequila  
I didn’t receive your email(s)
Sent you my info awhile back. 
Can you check if you have me in the ALT contact list 
Thanks

  
I didn’t receive your email(s)
Sent you my info awhile back. 
Can you check if you have me in the ALT contact list 
Thanks

@Diapers_Tequila I like it. Curious why so against options as a play, if even not supplemental to shares. Given the relative confidence in a sure thing (of which over a reasonable timeline, say next 3-6 months) to which I agree, the calls are pretty attractive. Just curious.

 I like it. Curious why so against options as a play, if even not supplemental to shares. Given the relative confidence in a sure thing (of which over a reasonable timeline, say next 3-6 months) to which I agree, the calls are pretty attractive. Just curious.

jk1566

@Diapers_Tequila nothing against you or anything but you shouldnt make claims about know there will be a buyout or promising the process has started…because these things you dont know for sure and you are most likely wrong and theres gullible people on this board that will buy shares because of this post and most likey lose money

 nothing against you or anything but you shouldnt make claims about know there will be a buyout or promising the process has started…because these things you dont know for sure and you are most likely wrong and theres gullible people on this board that will buy shares because of this post and most likey lose money

@Diapers_Tequila 

Wow, great post DT… 🙏🙏🙏

Jimbo

@Diapers_Tequila I cannot fathom how this will be sold for 5b or less.

Would love some rumours to come out soon. That article yesterday was a nice step in the right direction.

Mark Hogue

Dingus McKringleberry

Tom Snow

Justin Credible

 I cannot fathom how this will be sold for 5b or less.

Would love some rumours to come out soon. That article yesterday was a nice step in the right direction.

Benji596

@Blink182rulez I guess that is the risk of being on a message board for retail investors. You should head over to Orangebloods.com and check out the message boards  for college football portal movement and give those guys advice, they need it more than we do.

Patricia

Mr.Gayle Mack

Texas Longhorns fall 14-7 to Ohio State: Coach Sarkisian on Arch Manning's debut, red zone struggles, and key takeaways from the season opener.

Orangebloods

The Sunday Pulpit (via Loewy Law Firm): Perturbed? Sure. Panicked? Not yet

 I guess that is the risk of being on a message board for retail investors. You should head over to 

 and check out the message boards  for college football portal movement and give those guys advice, they need it more than we do.

@Diapers_Tequila They have raised substantial cash with their ATM IMO, on 12/19/25 and again on 1/6/26 which I estimate to be in the range of $75 M to $100 M, bringing their total cash to $325 to $375. I think this was a presequisite to the action you have projected; however, I feel very strongly that they will complete their discussions with the European Agencies and get full alignment on the PH3 protocal, and probably start File the protocal at clinicaltrials.com BEFORE they will do a deal with BP.  
 
Yes the negotiation is now ongoing. IMO, then now are giving access to the data to selected BP players with NDAs.  
 
Yes they can be entertaining some preliminary offers and deal sheets now.  
 
But there is NO WAY they will get their best deal until the BP can see exactly what the PH3 trial protocal will be.  
 
BP MUST know how many participants will be in the trial. BP MUST know alignment with the FDA on potential AA at 52 weeks. Only then, a maximum partnership deal can be reached, IMO.

brian duelfer

watsonturtle

Trialmed offers patient-focused clinical trials globally. Find a study, check your eligibility, and participate in cutting-edge medical research.

Trialmed

Global Clinical Trials & Research - Trialmed

 They have raised substantial cash with their ATM IMO, on 12/19/25 and again on 1/6/26 which I estimate to be in the range of $75 M to $100 M, bringing their total cash to $325 to $375. I think this was a presequisite to the action you have projected; however, I feel very strongly that they will complete their discussions with the European Agencies and get full alignment on the PH3 protocal, and probably start File the protocal at 

 BEFORE they will do a deal with BP.  
 
Yes the negotiation is now ongoing. IMO, then now are giving access to the data to selected BP players with NDAs.  
 
Yes they can be entertaining some preliminary offers and deal sheets now.  
 
But there is NO WAY they will get their best deal until the BP can see exactly what the PH3 trial protocal will be.  
 
BP MUST know how many participants will be in the trial. BP MUST know alignment with the FDA on potential AA at 52 weeks. Only then, a maximum partnership deal can be reached, IMO.

Ronald

@Blink182rulez Nothing against you or anything but we can tell you don&#39;t watch football.

robust8Billion

Patrick R.

Anthony

Markperk

Tee Bee

Diggs

7bilALTornothing

littlechj

Stew

Poksoloma

Michael

 Nothing against you or anything but we can tell you don't watch football.

@Diapers_Tequila  Flip Flop or Flip and Flop ?

Maxi Driver

@Diapers_Tequila 

Agreed, he’ll get the deal done, hopefully sooner rather than later.

And it sems Lee was quite responsive before, but has gone quiet on your end as well 🤔

 

Agreed, he’ll get the deal done, hopefully sooner rather than later.

And it sems Lee was quite responsive before, but has gone quiet on your end as well 🤔

FSDPSK

@Diapers_Tequila @Blink182rulez My thoughts  exactly;  and I’m a  girl!  🤷‍♀️😂

Robert Slovenz

 My thoughts  exactly;  and I’m a  girl!  🤷‍♀️😂

@FishStacker I had a few bounce back, send me another email at britt@texasonefund.org

 I had a few bounce back, send me another email at britt@texasonefund.org